All News about Bristol-Myers Squibb![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Via Benzinga
![]() ![]()
Bristol Myers' Deucravacitinib Scores FDA Approval For Plaque Psoriasis
September 12, 2022
Via Benzinga
![]() ![]() ![]()
Bristol Myers Squibb to Report Results for Third Quarter 2022 on October 26, 2022
September 07, 2022
From Bristol Myers Squibb
Via Business Wire
![]() ![]() ![]() ![]() ![]() Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|